BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31167206)

  • 21. MicroRNA 10a induces glioma tumorigenesis by targeting myotubularin-related protein 3 and regulating the Wnt/β-catenin signaling pathway.
    Yan Y; Yan H; Wang Q; Zhang L; Liu Y; Yu H
    FEBS J; 2019 Jul; 286(13):2577-2592. PubMed ID: 30927504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression.
    Wang Y; Wei Y; Tong H; Chen L; Fan Y; Ji Y; Jia W; Liu D; Wang G
    Cancer Biol Ther; 2015; 16(9):1308-15. PubMed ID: 26176806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of SOX7 via the Wnt signaling pathway.
    Bai QL; Hu CW; Wang XR; Shang JX; Yin GF
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5630-5637. PubMed ID: 29271996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-6807-3p promotes the tumorigenesis of glioma by targeting downstream DACH1.
    Lu GF; Geng F; Xiao Z; Chen YS; Han Y; You CY; Gong NL; Xie ZM; Pan M
    Brain Res; 2019 Apr; 1708():47-57. PubMed ID: 30527681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5.
    Wu J; Cui H; Zhu Z; Wang L
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1158-64. PubMed ID: 27545608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-362-3p regulates cell proliferation, migration and invasion of trophoblastic cells under hypoxia through targeting Pax3.
    Wang N; Feng Y; Xu J; Zou J; Chen M; He Y; Liu H; Xue M; Gu Y
    Biomed Pharmacother; 2018 Mar; 99():462-468. PubMed ID: 29665647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
    Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
    Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
    Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
    Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
    Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
    Liu Q; Yang G; Qian Y
    Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WWC3 Inhibits Glioma Cell Proliferation Through Suppressing the Wnt/β-Catenin Signaling Pathway.
    Wang Y; Jiang M; Yao Y; Cai Z
    DNA Cell Biol; 2018 Jan; 37(1):31-37. PubMed ID: 29115863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
    Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
    J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene.
    Shang C; Hong Y; Guo Y; Xue YX
    Med Sci Monit; 2016 Mar; 22():710-6. PubMed ID: 26936749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1.
    Shi HZ; Wang D; Sun XN; Sheng L
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3837-3846. PubMed ID: 29949160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA hsa_circ_0074362 Promotes Glioma Cell Proliferation, Migration, and Invasion by Attenuating the Inhibition of miR-1236-3p on HOXB7 Expression.
    Duan X; Liu D; Wang Y; Chen Z
    DNA Cell Biol; 2018 Nov; 37(11):917-924. PubMed ID: 30388035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
    Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
    Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.